Article
Lack of in vivo mutagenicity and oxidative DNA damage by flumequine in the livers of gpt delta mice.
Archives of toxicology - 1 Jan 2007
Kuroiwa Yuichi, Umemura Takashi, Nishikawa Akiyoshi, Kanki Keita, Ishii Yuji, Kodama Yukio, Masumura Ken-ichi, Nohmi Takehiko, Hirose Masao
Abstract excerpt
Flumequine (FLU), an anti-bacterial quinolone agent, has been recognized as a non-genotoxic carcinogen for the mouse liver, but recent reports have suggested that some genotoxic mechanism involving oxidative DNA damage may be responsible for its hepatocarcinogenesis. In the present study, we investigated this possibility in the mouse liver using male and female B6C3F1 gpt delta mice fed diet containing 0.4% FLU,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
